Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001469559-11-000026
Filing Date
2011-11-17
Accepted
2011-11-17 15:37:29
Documents
11
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A form10q93011v5.htm 10-Q/A 495190
3 EX 31.1 - CERTIFICATION ex311.htm EX-31 7701
4 EX 31.2 - CERTIFICATION ex312.htm EX-31 7596
5 EX 32.1 - CERTIFICATION ex321.htm EX-32 3505
6 EX 32.2 - CERTIFICATION ex322.htm EX-32 3610
  Complete submission text file 0001469559-11-000026.txt   1941104

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prot.ob-20110930_pre.xml EX-101.PRE 49913
7 XBRL INSTANCE DOCUMENT prot.ob-20110930.xml EX-101.INS 291802
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prot.ob-20110930.xsd EX-101.SCH 10112
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT prot.ob-20110930_cal.xml EX-101.CAL 5896
10 XBRL TAXONOMY EXTENSTION DEFINITION LINKBASE DOCUMENT prot.ob-20110930_def.xml EX-101.DEF 35980
11 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT prot.ob-20110930_lab.xml EX-101.LAB 67784
Mailing Address 187 MILL LANE MOUNTAINSIDE NJ 07052
Business Address 187 MILL LANE MOUNTAINSIDE NJ 07052 973-544-6116
PROTEONOMIX, INC. (Filer) CIK: 0001469559 (see all company filings)

EIN.: 133842844 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-53750 | Film No.: 111213007
SIC: 2834 Pharmaceutical Preparations